Warning letter
Home Care Pharmacy of Palm Coast, Inc.: warning letter of Aug 31, 2017
FDA warning letter 524658 · Dallas District Office
Key facts
| Reference number | 524658 |
|---|---|
| Company | Home Care Pharmacy of Palm Coast, Inc. |
| Subject | Drug Product/Adulterated |
| Issue date | Aug 31, 2017 |
| Posted date | Sep 19, 2017 |
| Issuing office | Dallas District Office |
| Product type | Drugs |
| CFR sections cited | 211.113(b), 211.42(c)(10)(iii), 201.115, 211.167(a), 211.42(c)(10)(v), 211.42(c)(10)(iv) |
| Inspection city | Palm Coast |
| Inspection ZIP | 32137 |
| Inspection start date | May 17, 2016 |
| Letter on fda.gov | fda.gov |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: